Systemic Anti-TNFα Treatment Restores Diabetes-Impaired Skin Repair in ob/ob Mice by Inactivation of Macrophages
Open accessThe DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.
Abstract
To date, diabetes-associated skin ulcerations represent a therapeutic problem of clinical importance. The insulin-resistant type II diabetic phenotype is functionally connected to obesity in rodent models of metabolic syndrome through the release of inflammatory mediators from adipose tissue. Here, we used the impaired wound-healing process in obese/obese (ob/ob) mice to investigate the impact of obesity-mediated systemic inflammation on cutaneous wound-healing processes. Systemic administration of neutralizing monoclonal antibodies against tumor necrosis factor (TNF)alpha (V1q) or monocyte/macrophage-expressed EGF-like module-containing mucin-like hormone receptor-like (Emr)-1 (F4/80) into wounded ob/ob mice at the end of acute wound inflammation initiated a rapid and complete neo-epidermal coverage of impaired wound tissue in the presence of a persisting diabetic phenotype. Wound closure in antibody-treated mice was paralleled by a marked attenuation of wound inflammation. Remarkably, anti-TNFalpha- and anti-F4/80-treated mice exhibited a strong reduction in circulating monocytic cells and reduced numbers of viable macrophages at the wound site. Our data provide strong evidence that anti-TNFalpha therapy, widely used in chronic inflammatory diseases in humans, might also exert effects by targeting "activated" TNFalpha-expressing macrophage subsets, and that inactivation or depletion of misbehaving macrophages from impaired wounds might be a novel therapeutic clue to improve healing of skin ulcers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies of impaired WH models of obese (ob/ob) and diabetic (db/db) mice have shown that the number of macrophages is elevated in those models [20].”
From Anti-Inflammatory and Skin Barrier Repair Effects of Topical Application of Some Plant Oils (2017) · cites this paper as [20]
In the citing paper
“Wound closure in obese mice (ob/ob) can be improved by systemic anti-tumor necrosis factor-alpha (TNF-α) treatment through inactivation of macrophages [20].”
From Anti-Inflammatory and Skin Barrier Repair Effects of Topical Application of Some Plant Oils (2017) · cites this paper as [20]
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426 · cited 1×
“RNA isolation and RNase protection analysis RNA isolation and RNase protection assays were carried out as described previously (Chomczynski and Sacchi, 1987; Frank et al., 1999).”
MethodPositional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419 · cited 1×
“The diseased phenotype is mediated by the functional loss of the ob gene product: the 16 kDa cytokine leptin (Zhang et al., 1994).”
BackgroundObesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“However, recent studies now implicate bone marrowrecruited macrophages located within adipose tissue rather than resident adipocytes to represent the cellular source of pro-inflammatory mediators in obesity (Weisberg et al., 2003).”
BackgroundAdipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189 · cited 2×
“Macrophages must be in an activated state to produce TNFa (Gordon, 2002; Mosser, 2003).”
BackgroundGlobal and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883 · cited 1×
“INTRODUCTION The last two decades have seen an explosive global increase in people diagnosed with diabetes mellitus (Zimmet et al., 2001).”
BackgroundC-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433 · cited 1×
“, 1997), and clinical studies confirmed that the presence of inflammatory mediators predicts the development of type II diabetes mellitus (Schmidt et al., 1999; Pradhan et al., 2001).”
BackgroundInflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143 · cited 1×
“RESULTS Short-term anti-TNFa (V1q) and anti-macrophage (F4/80) treatments did not improve metabolic syndrome in wounded ob/ob mice Adipose tissue-derived TNFa is considered to be functionally involved in obesity-associated insulin resistance (Hotamisligil et al., 1993; Wellen and Hotamisligil, 2005).”
BackgroundEffects of the obese Gene Product on Body Weight Regulation in ob / ob Mice
Pelleymounter, M. A., Cullen, M. J., Baker, M. B., Hecht, R., Winters, D., Boone, T., & Collins, F. (1995) · Science · doi:10.1126/science.7624776 · Cited by 4,017 · cited 1×
“Even a 16-day systemic leptin treatment of the mice, which served as control for correction of the metabolically disturbed phenotype (Figure 1c–e) and impaired healing in ob/ob mice (Pelleymounter et al., 1995; Frank et al., 2000; Ring et al., 2000; Goren et al., 2003, 2006), did not reduce serum TNFa levels (Figure 1…”
BackgroundRegulation of Wound Healing by Growth Factors and Cytokines
WERNER, S., & GROSE, R. (2003) · Physiological Reviews · doi:10.1152/physrev.2003.83.3.835 · Cited by 3,629
Adipocytokines: mediators linking adipose tissue, inflammation and immunity
Tilg, H., & Moschen, A. R. (2006) · Nature Reviews Immunology · doi:10.1038/nri1937 · Cited by 3,188
Wound healing and its impairment in the diabetic foot
Falanga, V. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67700-8 · Cited by 2,639 · cited 1×
“Obviously, resident cells in diabetic ulcers are phenotypically altered with respect to their sensitivity toward exogenous signals (Falanga, 2005; Goren et al., 2006).”
BackgroundThe many faces of macrophage activation
Mosser, D. M. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0602325 · Cited by 1,902 · cited 2×
“Macrophages must be in an activated state to produce TNFa (Gordon, 2002; Mosser, 2003).”
BackgroundF4/80, a monoclonal antibody directed specifically against the mouse macrophage
Austyn, J. M., & Gordon, S. (1981) · European Journal of Immunology · doi:10.1002/eji.1830111013 · Cited by 1,579
CCR2 modulates inflammatory and metabolic effects of high-fat feeding
Weisberg, S. P., Hunter, D., Huber, R., Lemieux, J., Slaymaker, S., Vaddi, K., Charo, I., Leibel, R. L., & Jr., A. W. F. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24335 · Cited by 1,497
The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum.
(1975) · PubMed Central · Cited by 1,437
CCR2 modulates inflammatory and metabolic effects of high-fat feeding
Weisberg, S. P. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24335c1 · Cited by 1,425
Inflammatory cells during wound repair: the good, the bad and the ugly
Martin, P., & Leibovich, S. J. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.09.002 · Cited by 1,340 · cited 1×
“In a recent review, Leibovich questioned his early statement that ‘‘it has largely been considered taboo to tinker too heavily with the inflammatory response at the wound site for fear of aborting this process’’ (Martin and Leibovich, 2005).”
BackgroundObese and diabetes: Two mutant genes causing diabetes-obesity syndromes in mice
Coleman, D. L. (1978) · Diabetologia · doi:10.1007/bf00429772 · Cited by 1,307 · cited 1×
“These mice are characterized by severe diabetes and obesity syndromes (Coleman, 1978).”
BackgroundKern, P. A., Saghizadeh, M., Ong, J. M., Bosch, R. J., Deem, R., & Simsolo, R. B. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117899 · Cited by 1,305 · cited 1×
“Interestingly, plasma TNFa levels were also dependent on adipose tissue mass in humans (Kern et al., 1995; Mantzoros et al., 1997), and clinical studies confirmed that the presence of inflammatory mediators predicts the development of type II diabetes mellitus (Schmidt et al.”
BackgroundSchmidt, M. I., Duncan, B. B., Sharrett, A. R., Lindberg, G., Savage, P. J., Offenbacher, S., Azambuja, M. I., Tracy, R. P., & Heiss, G. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01046-6 · Cited by 1,071 · cited 1×
“, 1997), and clinical studies confirmed that the presence of inflammatory mediators predicts the development of type II diabetes mellitus (Schmidt et al., 1999; Pradhan et al., 2001).”
BackgroundJeffcoate, W. J., & Harding, K. G. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13169-8 · Cited by 1,050
Wieman, T. J., Smiell, J. M., & Su, Y. (1998) · Diabetes Care · doi:10.2337/diacare.21.5.822 · Cited by 682
PD-1:PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2
Carter, L. L., Fouser, L. A., Jussif, J., Fitz, L., Deng, B., Wood, C. R., Collins, M., Honjo, T., Freeman, G. J., & Carreno, B. M. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200203)32:3<634::aid-immu634>3.0.co;2-9 · Cited by 673
Loots, M. A. M., Lamme, E. N., Zeegelaar, J., Mekkes, J. R., Bos, J. D., & Middelkoop, E. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00381.x · Cited by 620 · cited 1×
“It is known that macrophage numbers are markedly elevated in human chronic leg ulcers (Rosner et al., 1995; Loots et al., 1998) and in chronic wounds of genetically diabetic and obese db/db and ob/ob mouse models (Wetzler et al.”
BackgroundLügering, A., Schmidt, M., Lügering, N., Pauels, H.-G., Domschke, W., & Kucharzik, T. (2001) · Gastroenterology · doi:10.1053/gast.2001.28702 · Cited by 588 · cited 1×
“One possibility to explain the discrepancy between unchanged circulating TNFa levels and improved skin repair might arise from binding of V1q to membranebound TNFa in monocytes/macrophages (Solomon et al., 1999; Lügering et al., 2001) with a subsequent depletion of the cells by induction of apoptosis and/or complement…”
BackgroundWetzler, C., Kämpfer, H., Stallmeyer, B., Pfeilschifter, J., & Frank, S. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00029.x · Cited by 584 · cited 2×
“Short-term anti-TNFa (V1q) or anti-macrophage (F4/80) treatments markedly attenuated wound inflammatory conditions Leptin-driven skin repair in ob/ob mice was associated with a marked decline in wound inflammation following the acute phase of repair, whereas chronic healing conditions exhibited a sustained inflammator…”
BackgroundSelf-citationLong‐term prognosis for diabetic patients with foot ulcers
APELQVIST, J., LARSSON, J., & AGARDH, C. ‐. (1993) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1993.tb01003.x · Cited by 491 · cited 1×
“, 1995) and the 3-year survival rates after limb amputations are between 50 and 59%, as assessed for Italy and Sweden, respectively (Apelqvist et al., 1993; Faglia et al., 2001).”
BackgroundEchtenacher, B., Falk, W., Männel, D. N., & Krammer, P. H. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.11.3762 · Cited by 433 · cited 2×
“To this end, we injected a monoclonal antibody against murine TNFa (V1q) (Echtenacher et al., 1990) into wounded ob/ob mice.”
MethodFrank, S., Stallmeyer, B., Kämpfer, H., Kolb, N., & Pfeilschifter, J. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9148 · Cited by 304 · cited 4×
“Leptin administration of animals, starting at day 2 before wounding, is well established to mediate a robust improvement of impaired wounds in ob/ob mice (Frank et al., 2000; Ring et al., 2000; Goren et al., 2003, 2006).”
BackgroundSelf-citationMantzoros, C. S., Moschos, S., Avramopoulos, I., Kaklamani, V., Liolios, A., Doulgerakis, D. E., Griveas, I., Katsilambros, N., & Flier, J. S. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.10.4323 · Cited by 274
Stallmeyer, B., Kämpfer, H., Kolb, N., Pfeilschifter, J., & Frank, S. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00784.x · Cited by 238
Self-citationFrank, S., Stallmeyer, B., Kämpfer, H., Kolb, N., & Pfeilschifter, J. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.14.2002 · Cited by 232 · cited 2×
“Wounding of mice Wounding of mice was performed as described previously (Frank et al., 1999; Stallmeyer et al., 1999).”
MethodSelf-citationAdalimumab induces apoptosis of human monocytes: a comparative study with infliximab and etanercept
Shen, C., Assche, G. V., Colpaert, S., Maerten, P., Geboes, K., Rutgeerts, P., & Ceuppens, J. L. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02309.x · Cited by 223
Hirsch, S., Austyn, J. M., & Gordon, S. (1981) · The Journal of experimental medicine · doi:10.1084/jem.154.3.713 · Cited by 213 · cited 3×
“Thus, TNFa neutralization using systemically applied antibodies has to be regarded as an epiphenomenon with respect to the observed beneficial effects of the anti-TNFa therapy on impaired wound healing, as we obtained a comparable effect with respect to circulating monocyte numbers and improval of skin repair using an…”
BackgroundMethodInfluentialLong-Term Costs for Foot Ulcers in Diabetic Patients in a Multidisciplinary Setting
Apelqvist, J., Ragnarson-Tennvall, G., Larsson, J., & Persson, U. (1995) · Foot & Ankle International · doi:10.1177/107110079501600702 · Cited by 205 · cited 1×
“Diabetic ulcers still have a poor prognosis (Apelqvist et al., 1995) and the 3-year survival rates after limb amputations are between 50 and 59%, as assessed for Italy and Sweden, respectively (Apelqvist et al.”
BackgroundFaglia, E., Favales, F., & Morabito, A. (2001) · Diabetes Care · doi:10.2337/diacare.24.1.78 · Cited by 200
Severely Impaired Insulin Signaling in Chronic Wounds of Diabetic ob/ob Mice
Goren, I., Müller, E., Pfeilschifter, J. M., & Frank, S. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050293 · Cited by 162
Self-citationSystemically and Topically Administered Leptin Both Accelerate Wound Healing in Diabetic ob/ob Mice
Ring, B. D. (2000) · Endocrinology · doi:10.1210/en.141.1.446 · Cited by 121 · cited 2×
“Leptin administration of animals, starting at day 2 before wounding, is well established to mediate a robust improvement of impaired wounds in ob/ob mice (Frank et al., 2000; Ring et al., 2000; Goren et al., 2003, 2006).”
BackgroundSolomon, K. A., Pesti, N., Wu, G., & Newton, R. C. (1999) · PubMed · Cited by 100
Leptin and Wound Inflammation in Diabetic ob/ob Mice
Goren, I., Kämpfer, H., Podda, M., Pfeilschifter, J., & Frank, S. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2821 · Cited by 95 · cited 2×
“Short-term anti-TNFa (V1q) or anti-macrophage (F4/80) treatments markedly attenuated wound inflammatory conditions Leptin-driven skin repair in ob/ob mice was associated with a marked decline in wound inflammation following the acute phase of repair, whereas chronic healing conditions exhibited a sustained inflammator…”
BackgroundSelf-citationSolomon, K. A., Pesti, N., Wu, G., & Newton, R. C. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.8.4105 · Cited by 84 · cited 3×
“One possibility to explain the discrepancy between unchanged circulating TNFa levels and improved skin repair might arise from binding of V1q to membranebound TNFa in monocytes/macrophages (Solomon et al., 1999; Lügering et al., 2001) with a subsequent depletion of the cells by induction of apoptosis and/or complement…”
BackgroundShen, C., Assche, G. V., Rutgeerts, P. J., & Ceuppens, J. L. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000194185.69800.07 · Cited by 71
Rosner, K., Ross, C., Karlsmark, T., Petersen, A. A., Gottrup, F., & Vejlsgaard, G. L. (1995) · APMIS · doi:10.1111/j.1699-0463.1995.tb01109.x · Cited by 63 · cited 1×
“It is known that macrophage numbers are markedly elevated in human chronic leg ulcers (Rosner et al., 1995; Loots et al., 1998) and in chronic wounds of genetically diabetic and obese db/db and ob/ob mouse models (Wetzler et al.”
Background
Research works printed but not linked: 1
- Nauta, 2002, The membrane attack complex of complement induces caspase activation and apoptosis, Eur J Immunol, 32, 783, 10.1002/1521-4141(200203)32:3<783::AID-IMMU783>3.0.CO;2-Q · DOI · Paper page
Cited by
Krzyszczyk, P., Schloss, R., Palmer, A., & Berthiaume, F. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00419 · Cited by 1,546
“Goren et al. (2007) aimed to silence M1 macrophages in obese/obese (ob/ob) mouse wounds (Goren et al., 2007).”
BackgroundMacrophage Phenotypes Regulate Scar Formation and Chronic Wound Healing
Hesketh, M., Sahin, K. B., West, Z. E., & Murray, R. Z. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071545 · Cited by 852
“TNF is one of the key cytokines that can impair wound healing [52].”
BackgroundAnti-Inflammatory and Skin Barrier Repair Effects of Topical Application of Some Plant Oils
Lin, T.-K., Zhong, L., & Santiago, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms19010070 · Cited by 759
“Studies of impaired WH models of obese (ob/ob) and diabetic (db/db) mice have shown that the number of macrophages is elevated in those models [20].”
BackgroundMacrophage Dysfunction Impairs Resolution of Inflammation in the Wounds of Diabetic Mice
Khanna, S., Biswas, S., Shang, Y., Collard, E., Azad, A., Kauh, C., Bhasker, V., Gordillo, G. M., Sen, C. K., & Roy, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009539 · Cited by 694
“Diabetic macrophages produce high levels of proinflammatory cytokines [8,9].”
BackgroundMacrophage polarization in pathology
Sica, A., Erreni, M., Allavena, P., & Porta, C. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1995-y · Cited by 673
“diabetes exhibit impaired healing and over-accumulation of macrophages, whose depletion accelerates wound closure [46, 47].”
Background
Metadata
- Authors
- Goren, I., Müller, E., Schiefelbein, D., Christen, U., Pfeilschifter, J., Mühl, H., & Frank, S.
- Affiliations
- Goethe University Frankfurt (DE)
- Corresponding author
- Frank, Stefan
- Venue
- Journal of Investigative Dermatology
- Publisher
- Elsevier BV
- Published
- 2007-09
- Volume
- 127
- Issue
- 9
- Pages
- 2259-2267
- ISSN
- 0022-202X (ISSN-L)
- OpenAlex
- W1966999008
- Cited by
- 151
- References
- 45
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 9 · 2023: 7 · 2022: 7 · 2021: 8 · 2020: 8 · 2019: 9 · 2018: 7 · 2017: 8 · 2016: 12 · 2015: 9 · 2014: 8 · 2013: 7 · 2012: 9
- FWCI
- 10.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 3014 d)
- Locations
- Journal of Investigative Dermatology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Topics
- Health Sciences › Medicine › Surgery › Wound Healing and Treatments
- Health Sciences › Medicine › Dermatology › Skin Diseases and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetic Foot Ulcer Assessment and Management
- Keywords
- anti-TNF therapy, TNF-α, wound healing, diabetic skin ulcers, obesity, ob/ob mice, type 2 diabetes, systemic inflammation, F4/80, monocytic cells, adipose tissue inflammation, metabolic syndrome, monoclonal antibodies
- MeSH terms
- Adipose Tissue, Animals, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 2, Inflammation, Macrophages, Mice, Obese, Monocytes, Phenotype, Skin, Tumor Necrosis Factor-alpha, Wound Healing, Apoptosis, Diabetes Complications, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.